Check out the most recent, most relevant statistics on HIV in the United States and U.S. territories. Information provided by the Center for Disease Control & Prevention.
Cancer Rates on the Decline in the United StatesSherif El Refai
Sherif Mohamed El-Refai serves as an oncology pharmacist at Markey Cancer Center, a part of the University of Kentucky. Also working toward a PhD in pharmaceutical sciences from the university, Sherif Mohamed El-Refai affiliates with the American Pharmacists Association (APhA), a professional organization committed to improving patient care through the use of medication.
How many moustaches are present in the newly minted 113th Congress? What percentage of women comprise the Senate? Discover the answers and many interesting facts in this slideshow about our U.S. representatives.
As providers face increasing regulation, it is critical to understand the driving forces behind these laws, the barriers to adoption, and the practical ways these new rules can be turned into opportunities. Learn the history and importance of recent legislation (including ARRA and HITECH), the purpose and practical implications of Meaningful Use, an overview of requirements for Meaningful Use Stage 1 and updates on Stage 2.
The U.S. is on the brink of wading into the waters of improving clinical decision making through the use of technology at the point of care and within the practice design. Legislation supports it. Patient-centered medical home supports it. Health policy supports it. More and more, practices are adopting it—and wisely so, since compliance with quality guidelines will likely affect reimbursements in the future.
Cancer Rates on the Decline in the United StatesSherif El Refai
Sherif Mohamed El-Refai serves as an oncology pharmacist at Markey Cancer Center, a part of the University of Kentucky. Also working toward a PhD in pharmaceutical sciences from the university, Sherif Mohamed El-Refai affiliates with the American Pharmacists Association (APhA), a professional organization committed to improving patient care through the use of medication.
How many moustaches are present in the newly minted 113th Congress? What percentage of women comprise the Senate? Discover the answers and many interesting facts in this slideshow about our U.S. representatives.
As providers face increasing regulation, it is critical to understand the driving forces behind these laws, the barriers to adoption, and the practical ways these new rules can be turned into opportunities. Learn the history and importance of recent legislation (including ARRA and HITECH), the purpose and practical implications of Meaningful Use, an overview of requirements for Meaningful Use Stage 1 and updates on Stage 2.
The U.S. is on the brink of wading into the waters of improving clinical decision making through the use of technology at the point of care and within the practice design. Legislation supports it. Patient-centered medical home supports it. Health policy supports it. More and more, practices are adopting it—and wisely so, since compliance with quality guidelines will likely affect reimbursements in the future.
This presentation highlights the most recent statistics on AIDS in the United States and U.S. territories. The information is provided by the Center for Disease Control & Prevention.
Was your Sex Ed lacking? Find the missing chapter with iPROVIBE.com. "Let the Vibe be with you." -proVibe Promoting Self-Love - Sex Ed - Dating Prerequisites - Wellness http://iprovibe.com/ http://gplus.to/iprovibe http://www.facebook.com/iprovibe https://twitter.com/iproVibe http://pinterest.com/iprovibe/
Comparing local epidemiology of Chlamydia in Miami- Dade County to that of State of Florida and the United States. Highlighting basic description of the disease, surveillance methods, reporting, control measures, epidemiology of the disease and comparison of 5 year trends/incident rates in Miami Dade County to that of State of Florida and the United States.
Global Medical Cures™ | HIV among YOUTH
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
This presentation offers stats, trends, and factors associated with higher HIV-infection risk and how clinicians can attend to it.This was my presentation for Bayless Bahavioral Health- Didactic training on 12.10.13, it explores the HIV problem in the US and AZ and
Ethnic differences in HIV-disclosure and sexual riskJason .docxelbanglis
Ethnic differences in HIV-disclosure and sexual risk
Jason D.P. Birda*, David D. Fingerhuta,b and David J. McKirnana,b
aDepartment of Research, Howard Brown Health Center, Chicago, IL, USA; bDepartment of Pscyhology, University of Illinois
at Chicago, Chicago, IL, USA
(Received 23 March 2010; final version received 7 July 2010)
Little is known about ethnic differences in HIV-disclosure to sexual partners or the relationship between HIV-
disclosure and sexual risk. Differences in HIV-disclosure rates between African-American and White men who
have sex with men (MSM) were analyzed using data from the Treatment Advocacy Program. In general, the
findings suggest that African-Americans are less likely than Whites to disclose their HIV status to sexual partners.
The findings also suggest that the African-American participants who disclosed to HIV-negative partners were
significantly less likely to engage in unprotected anal sex with HIV-negative partners and partners whose HIV
status was unknown than those participants who did not disclosure to HIV-negative partners. Although HIV-
disclosure appears to be an important factor to consider in HIV-prevention efforts, there are unique factors that
influence HIV-disclosure decisions for African-American MSM. Interventions should consider these unique
challenges before focusing on HIV-disclosure as a primary tool for reducing the transmission of HIV.
Keywords: HIV/AIDS; HIV prevention; African-Americans; men who have sex with men
Background/Significance
Racial disparities in new HIV infections have become
increasingly pronounced, with African-Americans
accounting for over 50% of all newly diagnosed
HIV/AIDS cases in 2007 (CDC, 2009). Moreover,
African-American men who have sex with men
(MSM) are a highly vulnerable subgroup with
epidemiological data showing they are twice as likely
as White MSM to become infected with HIV (CDC,
2009). In response to these rising infection rates,
prevention efforts have shifted toward more routine
testing and a greater emphasis on prevention inter-
ventions with HIV-positive individuals (CDC, 2009;
Crepaz & Marks, 2003; Gorbach et al., 2004;
Sullivan, 2005). These intervention shifts will inevi-
tably fuel the debate regarding the relationship
between HIV-disclosure and sexual risk. Given the
racial differences in HIV transmission rates, it is
possible that HIV-related behavior, such as HIV
status disclosure, will show similar disparities and
this study seeks to explicitly examine what racial
differences in HIV-disclosure to sexual partners might
exist.
Debate continues regarding the cause of racial
disparities in the rates of HIV infection. Research
shows that African-American MSM are not more
sexually risky and do not have significantly more
sexual partners than their White counterparts (Millett,
Flores, Peterson, & Bakeman, 2007; Millett, Peterson,
Wolitski, & Stall, 2006). Recent data does suggest,
however, that riskier sexual netw ...
HIV/AIDS: Hispanic/Latino Disparities and Policy Recommendations
Daniel Santibanez, MPH, Department of Public Health, University of North Florida
Donna T. Jones, MS, RD, LD/N, Medical Nutrition Therapy of Florida, Inc.
July 22, 2005 - UNF Hispanic Health Issues Seminar
This is part 6 of an 8 part series of seminars on Hispanic Health Issues brought to you by the University of North Florida’s Dept. of Public Health, College of Health, a grant from AETNA, and the cooperation of Duval County Health Department.
Global Medical Cures™ | HIV Among Women
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Do you know everything you need to know about Medicaid's Meaningful Use program? Watch this video to learn more about Meaningful Use's eligibility, registration and timeline.
This presentation highlights the most recent statistics on AIDS in the United States and U.S. territories. The information is provided by the Center for Disease Control & Prevention.
Was your Sex Ed lacking? Find the missing chapter with iPROVIBE.com. "Let the Vibe be with you." -proVibe Promoting Self-Love - Sex Ed - Dating Prerequisites - Wellness http://iprovibe.com/ http://gplus.to/iprovibe http://www.facebook.com/iprovibe https://twitter.com/iproVibe http://pinterest.com/iprovibe/
Comparing local epidemiology of Chlamydia in Miami- Dade County to that of State of Florida and the United States. Highlighting basic description of the disease, surveillance methods, reporting, control measures, epidemiology of the disease and comparison of 5 year trends/incident rates in Miami Dade County to that of State of Florida and the United States.
Global Medical Cures™ | HIV among YOUTH
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
This presentation offers stats, trends, and factors associated with higher HIV-infection risk and how clinicians can attend to it.This was my presentation for Bayless Bahavioral Health- Didactic training on 12.10.13, it explores the HIV problem in the US and AZ and
Ethnic differences in HIV-disclosure and sexual riskJason .docxelbanglis
Ethnic differences in HIV-disclosure and sexual risk
Jason D.P. Birda*, David D. Fingerhuta,b and David J. McKirnana,b
aDepartment of Research, Howard Brown Health Center, Chicago, IL, USA; bDepartment of Pscyhology, University of Illinois
at Chicago, Chicago, IL, USA
(Received 23 March 2010; final version received 7 July 2010)
Little is known about ethnic differences in HIV-disclosure to sexual partners or the relationship between HIV-
disclosure and sexual risk. Differences in HIV-disclosure rates between African-American and White men who
have sex with men (MSM) were analyzed using data from the Treatment Advocacy Program. In general, the
findings suggest that African-Americans are less likely than Whites to disclose their HIV status to sexual partners.
The findings also suggest that the African-American participants who disclosed to HIV-negative partners were
significantly less likely to engage in unprotected anal sex with HIV-negative partners and partners whose HIV
status was unknown than those participants who did not disclosure to HIV-negative partners. Although HIV-
disclosure appears to be an important factor to consider in HIV-prevention efforts, there are unique factors that
influence HIV-disclosure decisions for African-American MSM. Interventions should consider these unique
challenges before focusing on HIV-disclosure as a primary tool for reducing the transmission of HIV.
Keywords: HIV/AIDS; HIV prevention; African-Americans; men who have sex with men
Background/Significance
Racial disparities in new HIV infections have become
increasingly pronounced, with African-Americans
accounting for over 50% of all newly diagnosed
HIV/AIDS cases in 2007 (CDC, 2009). Moreover,
African-American men who have sex with men
(MSM) are a highly vulnerable subgroup with
epidemiological data showing they are twice as likely
as White MSM to become infected with HIV (CDC,
2009). In response to these rising infection rates,
prevention efforts have shifted toward more routine
testing and a greater emphasis on prevention inter-
ventions with HIV-positive individuals (CDC, 2009;
Crepaz & Marks, 2003; Gorbach et al., 2004;
Sullivan, 2005). These intervention shifts will inevi-
tably fuel the debate regarding the relationship
between HIV-disclosure and sexual risk. Given the
racial differences in HIV transmission rates, it is
possible that HIV-related behavior, such as HIV
status disclosure, will show similar disparities and
this study seeks to explicitly examine what racial
differences in HIV-disclosure to sexual partners might
exist.
Debate continues regarding the cause of racial
disparities in the rates of HIV infection. Research
shows that African-American MSM are not more
sexually risky and do not have significantly more
sexual partners than their White counterparts (Millett,
Flores, Peterson, & Bakeman, 2007; Millett, Peterson,
Wolitski, & Stall, 2006). Recent data does suggest,
however, that riskier sexual netw ...
HIV/AIDS: Hispanic/Latino Disparities and Policy Recommendations
Daniel Santibanez, MPH, Department of Public Health, University of North Florida
Donna T. Jones, MS, RD, LD/N, Medical Nutrition Therapy of Florida, Inc.
July 22, 2005 - UNF Hispanic Health Issues Seminar
This is part 6 of an 8 part series of seminars on Hispanic Health Issues brought to you by the University of North Florida’s Dept. of Public Health, College of Health, a grant from AETNA, and the cooperation of Duval County Health Department.
Global Medical Cures™ | HIV Among Women
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Do you know everything you need to know about Medicaid's Meaningful Use program? Watch this video to learn more about Meaningful Use's eligibility, registration and timeline.
Accountable Care Organizations: 4 Physician BenefitsGreenway Health
Why would physicians join an Accountable Care Oragnization (ACO)? This informative slide presentation gives a brief overview of ACOs, their benefits, and four reasons physicians may have for joining one.
The Marketplace - Insurance Exchanges and ProvidersGreenway Health
Exploring coverage options through the Marketplace a/k/a Health Insurance Exchange (HIX) is among a growing lexicon of terms for governmental and insurance stakeholders. Intended to provide the consumer with an intuitive way to shop coverage with built-in protections, HIX open enrollment launches Oct. 1, 2013 and offers assistance with coverage choices and comparisons, calculation of costs, and education on public program options. Some HIXs will be run by state governments while others will be administered wholly or in partnership with the federal government. Explore the four exchange tiers, what constitutes "essential benefits" and "essential community providers," the role consumer assistants such as navigators in facilitating coverage for each American, and what providers and practices should be doing today to prepare. Review the basic functions of the HIX and the available subsidies for individuals and families. Regulations on Medicaid eligibility expansion will also be covered, as well as the impact on adult coverage and the future HIX milestones.
Source: Webinar presented August 28, 2013 by Adele Allison, National Director of Government Affairs for SuccessEHS
6 Tips to Leverage EHR Patient Data EffectivelyGreenway Health
If you have an EHR and practice management system, you have a very valuable asset at your fingertips: patient level health data. This presentation covers six practical ways your organization can use the data you already have to improve financial and clinical practice performance and position for coming value-based reimbursement.
How much money have the Meaningful Use Incentive Programs paid so far? Which states are the biggest adopters of new health care technology and which ones are behind? Discover the total amount providers, hospitals and eligible professionals are getting paid in Medicare and Medicaid incentives.
Recently, a study published in the Journal of the American Dental Association shows a growing trend among U.S. dentists to incorporate EDR technology into their practice. Learn about how technology adoption has changed over the last decade among dentists, as well as how they are using the technology in their practices.
The Top 10 Tech Trends that affect health care organizations and providers. Includes organization considerations and optimum implementation timeline. (Source: Health Data Management)
Patient Engagement & the Matrix: How plugged in are we?Greenway Health
Americans are plugged in to "the Matrix" more than ever. Read about the digital and mobile habits of the American patient and how this has crossed over into health care.
What's the difference between fraud, waste and abuse when it comes to health care? What is the government doing to prevent fraud, waste and abuse from happening? Learn the definitions and differences in these legal terms and how CMS has worked to prevent these from happening since its inception in 1965.
Meaningful Use measures can be categorized into four distinct "buckets." Adele Allison, National Director of Government Affairs at SuccessEHS, defines the four different marks of Meaningful Use and the health IT goals that go along with each one. She also presents which categories are going to be significant moving forward into Stage 2, as well as how the categories will impact providers and reimbursement reform.
Medicaid Incentive Payouts and Stage 2 Meaningful UseGreenway Health
Adele Allison, National Director of Government Affairs at SuccessEHS, explains the details and deadlines providers need to know for Medicaid Meaningful Use. She highlights the incentive payouts for meeting Stage One, as well as the changes Stage 2 brings for both Medicare and Medicaid.
For a copy of the Medicaid Timeline, visit our blog: info.successehs.com/blog
How will Medicare pay providers who successfully attest to Meaningful Use? This slideshow highlights the timeline and details of Medicare incentive payouts. To view, print or download a copy of the timeline, visit our blog at http://info.successehs.com/blog/
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. Diagnoses of HIV in 2009
In 2009, the estimated number of diagnoses of HIV
infection in the 40 states and 5 U.S. dependent
areas with confidential name-based HIV infection
reporting was 42,959. Of these, 42,011 were in
the 40 states and 948 were in the 5 dependent
areas.
3. 40 States and 5 U.S. Dependent Areas
with Confidential Name-Based HIV
Infection Reporting:
Alabama, Alaska, Arizona, Arkansas, Colorado, Connecticut,
Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas,
Kentucky, Louisiana, Maine, Michigan, Minnesota,
Mississippi, Missouri, Nebraska, Nevada, New Hampshire,
New Jersey, New Mexico, New York, North Carolina, North
Dakota, Ohio, Oklahoma, Pennsylvania, South Carolina,
South Dakota, Tennessee, Texas, Utah, Virginia, West
Virginia, Wisconsin, Wyoming, American Samoa, Guam, the
Northern Mariana Islands, Puerto Rico, and the U.S. Virgin
Islands.
4. Diagnoses of HIV in 2009
In the 40 states, diagnoses of HIV infection among
adults and adolescents totaled 41,845.
31,872 diagnoses in males
9,973 diagnoses in females
166 diagnoses among children under age 13 years
5. Race or Ethnicity Diagnoses of HIV
American Indian/Alaska Native
- 2009: 189
Asian
- 2009: 470
Black/African American
- 2009: 21,652
Hispanic/Latino
- 2009: 7,347
6. Race or Ethnicity Diagnoses of HIV
Native Hawaiian/Other Pacific Islander
- 2009: 34
White
- 2009: 11,803
Multiple Races
- 2009: 516
8. 2009 HIV Diagnoses by Top 10 Age
Categories
8. Ages 15 - 19
- 2009: 2,036
9. Ages 55 - 59
- 2009: 2,004
10. Ages 60 - 64
- 2009: 900
9. HIV Diagnoses by Transmission
Category in 2009
Adult & Adolescent Males
-Male-to-male sexual contact
-2009: 23,846
-Injection drug use
-2009: 2,449
-Heterosexual contact
-2009: 4,399
10. HIV Diagnoses by Transmission
Category in 2009
Adult & Adolescent Males
-Male-to-male sexual contact & injection drug use
-2009: 1,131
-Other (includes hemophilia, blood transfusion,
perinatal exposure & risk not reported)
-2009: 47
11. HIV Diagnoses by Transmission
Category in 2009
Adult & Adolescent Females
-Injection drug use
-2009: 1,483
-Heterosexual contact
-2009: 8,461
-Other (includes hemophilia, blood transfusion,
perinatal exposure & risk not reported)
-2009: 29
12. HIV Diagnoses by Transmission
Category in 2009
Under age 13
-Perinatal
-2009: 131
-Other (includes hemophilia, blood transfusion &
risk not reported)
-2009: 35
13. For more information, please visit
http://www.cdc.gov/hiv/topics/surveillance/b
.
Here, you will find the CDC’s “HIV
Surveillance Report” and a wealth of
other HIV/AIDS-related resources.